Picture of Fonar logo

FONR Fonar Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedSmall CapContrarian

Annual income statement for Fonar, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue89.997.698.6103104
Cost of Revenue
Gross Profit43.54745.745.142.9
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses72.875.683.986.392.8
Operating Profit17.12214.816.511.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes17.722.815.819.313.8
Provision for Income Taxes
Net Income After Taxes13.717.212.114.110.7
Minority Interest
Net Income Before Extraordinary Items
Net Income10.212.49.3810.68.33
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income9.5911.78.89.917.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS1.371.651.251.441.16